Copyright
©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1441-1449
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1441
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1441
Variable | Death group (n = 12) | Improved group (n = 60) | χ2 | P value | |
ICU | No | 8 (66.7) | 59 (98.3) | 21.278 | 0.001b |
Arteriovenous catheterization | Yes | 4 (33.3) | 1 (1.7) | 15.518 | 0.000b |
Tracheal intubation | Yes | 4 (33.3) | 1 (1.7) | 15.518 | 0.000b |
Catheterization cannula | Yes | 4 (33.3) | 1 (1.7) | 15.518 | 0.000b |
No antibiotics | Yes | 12 (100) | 54 (90) | 1.309 | 0.253 |
Quinolones | Yes | 3 (25) | 14 (23.3) | 0.015 | 0.901 |
Carbapenems | Yes | 10 (83.3) | 25 (41.7) | 6.950 | 0.008b |
First and second generations of cephalosporin | Yes | 1 (8.3) | 11 (18.3) | 0.720 | 0.396 |
Third-generation cephalosporin | Yes | 0 (0) | 10 (16.7) | 2.134 | 0.144 |
Antibiotics with an enzyme inhibitor | Yes | 5 (41.7) | 22 (36.7) | 0.107 | 0.744 |
Vancomycin | Yes | 3 (25) | 5 (8.3) | 0.094 |
- Citation: Zhang Y, Zhao H, Ji SB, Xing HC. Clinical analysis of Klebsiella pneumoniae infection in patients with liver cirrhosis in Beijing. World J Hepatol 2024; 16(12): 1441-1449
- URL: https://www.wjgnet.com/1948-5182/full/v16/i12/1441.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i12.1441